These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 26307676

  • 1. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
    Wang T, Yuan J, Zhang J, Tian R, Ji W, Zhou Y, Yang Y, Song W, Zhang F, Niu R.
    Oncotarget; 2015 Oct 13; 6(31):30975-92. PubMed ID: 26307676
    [Abstract] [Full Text] [Related]

  • 2. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
    Yuan J, Yang Y, Gao Z, Wang Z, Ji W, Song W, Zhang F, Niu R.
    Breast Cancer Res Treat; 2017 Jul 13; 164(2):327-340. PubMed ID: 28470457
    [Abstract] [Full Text] [Related]

  • 3. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
    Zhang F, Wang Z, Yuan J, Wei X, Tian R, Niu R.
    Breast Cancer Res Treat; 2015 Sep 13; 153(2):263-75. PubMed ID: 26253946
    [Abstract] [Full Text] [Related]

  • 4. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Zhao C, Zheng S, Yan Z, Deng Z, Wang R, Zhang B.
    Oncol Rep; 2020 Feb 13; 43(2):571-580. PubMed ID: 31894281
    [Abstract] [Full Text] [Related]

  • 5. Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction.
    Yue X, Zhao Y, Zhang C, Li J, Liu Z, Liu J, Hu W.
    Oncotarget; 2016 Jan 26; 7(4):3777-90. PubMed ID: 26716902
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E, Hansen MT, Haase M, Emons G, Gründker C.
    Breast Cancer Res Treat; 2014 Nov 26; 148(2):269-77. PubMed ID: 25292421
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. miR520c blocks EMT progression of human breast cancer cells by repressing STAT3.
    Wang N, Wei L, Huang Y, Wu Y, Su M, Pang X, Wang N, Ji F, Zhong C, Chen T, Li B.
    Oncol Rep; 2017 Mar 26; 37(3):1537-1544. PubMed ID: 28112380
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.